PharmaResearch Announces Acquisition of CG USA
PharmaResearch is acquiring CG USA, a move that expands its footprint in the North American market. For cosmetics B2B supply chains, the deal may reshape access to related ingredients and contract manufacturing services.
South Korea's PharmaResearch is proceeding with the acquisition of CG USA, though transaction details have not been disclosed in the available material. PharmaResearch has an established presence in beauty and health sectors, and this acquisition points to regional expansion in North America.
The specific business scope of CG USA is not detailed in the current information. Given PharmaResearch's business profile, the deal may involve consolidation of cosmetics-related ingredients, R&D, or manufacturing resources, though the precise synergy direction awaits further disclosure.
For B2B buyers and brand owners, cross-border acquisitions often bring supply chain adjustments — including potential changes to distribution channels, ingredient supply agreements, and contract manufacturing terms. Procurement teams are advised to monitor post-closing entity change notices and promptly assess contract continuity and pricing implications.
Source:Pulse 2.0
Note: compiled and rewritten by BIOSPHERE editors from public reporting; illustration AI-generated. See the source for full details.